Alpa Laboratories Limited

NSEI:ALPA Stock Report

Market Cap: ₹2.2b

Alpa Laboratories Balance Sheet Health

Financial Health criteria checks 5/6

Alpa Laboratories has a total shareholder equity of ₹1.6B and total debt of ₹22.6M, which brings its debt-to-equity ratio to 1.4%. Its total assets and total liabilities are ₹2.0B and ₹343.6M respectively. Alpa Laboratories's EBIT is ₹64.2M making its interest coverage ratio -3. It has cash and short-term investments of ₹1.1B.

Key information

1.4%

Debt to equity ratio

₹22.61m

Debt

Interest coverage ratio-3x
Cash₹1.09b
Equity₹1.65b
Total liabilities₹343.55m
Total assets₹1.99b

Recent financial health updates

Recent updates

Insufficient Growth At Alpa Laboratories Limited (NSE:ALPA) Hampers Share Price

Apr 04
Insufficient Growth At Alpa Laboratories Limited (NSE:ALPA) Hampers Share Price

If EPS Growth Is Important To You, Alpa Laboratories (NSE:ALPA) Presents An Opportunity

Feb 13
If EPS Growth Is Important To You, Alpa Laboratories (NSE:ALPA) Presents An Opportunity

Alpa Laboratories Limited (NSE:ALPA) Looks Inexpensive But Perhaps Not Attractive Enough

Jan 03
Alpa Laboratories Limited (NSE:ALPA) Looks Inexpensive But Perhaps Not Attractive Enough

Increases to Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation Might Cool off for now

Sep 22
Increases to Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation Might Cool off for now

Alpa Laboratories Limited's (NSE:ALPA) Shares Bounce 32% But Its Business Still Trails The Market

Sep 06
Alpa Laboratories Limited's (NSE:ALPA) Shares Bounce 32% But Its Business Still Trails The Market

We Think That There Are Issues Underlying Alpa Laboratories' (NSE:ALPA) Earnings

Jun 08
We Think That There Are Issues Underlying Alpa Laboratories' (NSE:ALPA) Earnings

Cautious Investors Not Rewarding Alpa Laboratories Limited's (NSE:ALPA) Performance Completely

Jun 03
Cautious Investors Not Rewarding Alpa Laboratories Limited's (NSE:ALPA) Performance Completely

Here's Why We Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Dec 14
Here's Why We Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Shareholders May Not Be So Generous With Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation And Here's Why

Sep 23
Shareholders May Not Be So Generous With Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation And Here's Why

Here's Why Alpa Laboratories (NSE:ALPA) Has Caught The Eye Of Investors

Aug 26
Here's Why Alpa Laboratories (NSE:ALPA) Has Caught The Eye Of Investors

Is Alpa Laboratories (NSE:ALPA) A Risky Investment?

Jan 19
Is Alpa Laboratories (NSE:ALPA) A Risky Investment?

Is Now The Time To Put Alpa Laboratories (NSE:ALPA) On Your Watchlist?

Jun 17
Is Now The Time To Put Alpa Laboratories (NSE:ALPA) On Your Watchlist?

If You Like EPS Growth Then Check Out Alpa Laboratories (NSE:ALPA) Before It's Too Late

Feb 23
If You Like EPS Growth Then Check Out Alpa Laboratories (NSE:ALPA) Before It's Too Late

Alpa Laboratories' (NSE:ALPA) Earnings Aren't As Good As They Appear

Nov 24
Alpa Laboratories' (NSE:ALPA) Earnings Aren't As Good As They Appear

Here's Why I Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Oct 05
Here's Why I Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Do Alpa Laboratories's (NSE:ALPA) Earnings Warrant Your Attention?

May 31
Do Alpa Laboratories's (NSE:ALPA) Earnings Warrant Your Attention?

With EPS Growth And More, Alpa Laboratories (NSE:ALPA) Is Interesting

Jan 28
With EPS Growth And More, Alpa Laboratories (NSE:ALPA) Is Interesting

Financial Position Analysis

Short Term Liabilities: ALPA's short term assets (₹1.8B) exceed its short term liabilities (₹319.6M).

Long Term Liabilities: ALPA's short term assets (₹1.8B) exceed its long term liabilities (₹24.0M).


Debt to Equity History and Analysis

Debt Level: ALPA has more cash than its total debt.

Reducing Debt: ALPA's debt to equity ratio has increased from 0.3% to 1.4% over the past 5 years.

Debt Coverage: ALPA's debt is well covered by operating cash flow (446.8%).

Interest Coverage: ALPA earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/05 01:20
End of Day Share Price 2025/05/05 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Alpa Laboratories Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anil BurraFirstCall Research